IN Control advanced course: INs and outs of INsulin INitiation and INtensification

You need to login to participate in this education.

Please log in, or if you don't already have a free account, register to continue.

This education is accredited: RACGP 40 CPD, ACRRM 5.00 CME PD.

This year we celebrate the centenary of the modern era of diabetology which began with the discovery of insulin in 1921 – the first, and oldest of our anti-diabetes medications. However, far from being old and crusty, newer, second-generation insulin analogues represent cutting-edge diabetes research and pharmacotherapy.

This GP-led, on-demand advanced course, supported by diabetes specialists, will provide practical guidance on the role and implementation of insulin in the contemporary management of diabetes in the primary care space.

On completion of this education activity participants will be able to:
  • Rationalise the use of insulin in the current T2D management landscape, using latest guidelines.
  • Evaluate the role of newer, second-generation analogue insulins when individualising patient treatment.
  • Implement simple models and tools to optimise insulin delivery.
  • Conduct an effective patient consult when initiating, intensifying or switching insulins.
  • Assess and consider the use of rapidly evolving technology in T2D management.
This activity is sponsored by Novo Nordisk.
Content partners: 
IN Control advanced course - Predisposing activity
IN Control advanced course - Session 1 of 5
IN Control advanced course - Session 2 of 5
IN Control advanced course - Session 3 of 5
IN Control advanced course - Session 4 of 5
IN Control advanced course - Session 5 of 5
IN Control advanced course - Reinforcing activity
IN Control advanced course - Evaluation